ForeseeHome NRich Registry

Active, not recruitingOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

December 15, 2027

Study Completion Date

December 15, 2027

Conditions
Age-Related Macular Degeneration
Interventions
DEVICE

Foresee Home

The ForeseeHome Monitoring System, a non-significant risk device, is prescribed by eye care providers to patients as part of their clinical care. Notal Vision Monitoring Center (NVMC) is an independent diagnostic testing facility responsible for clinical monitoring of FSH data. The NVMC communicates with the patients (for training on the use of the device, troubleshooting of device issues, adherence monitoring, etc.) and with the patients' eyecare providers (for reporting FSH alerts, monitoring of clinical outcomes to assess device functionality and ongoing need for the device, etc.).

Trial Locations (1)

08755

NJ Retina, Toms River

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Notal Vision Inc.

INDUSTRY

NCT05690880 - ForeseeHome NRich Registry | Biotech Hunter | Biotech Hunter